Gore Receives FDA Clearance for GORE® SYNECOR Preperitoneal Biomaterial Hernia Repair Device
Hybrid of unique bioabsorbable and permanent materials provide a single-stage hernia repair to help minimize complications in preperitoneal applications
Gore Joins Vascular and Endovascular Leaders in Recognizing the 2014 Pioneers in Performance for North America
Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy
Gore Launches Unique Biomaterial for Complex Ventral Hernia Repair
Gore to launch its new hybrid device, GORE® SYNECOR Biomaterial, at the 17th Annual Hernia Repair Conference in Washington, D.C.
Nominees Announced for 2013-2014 Pioneers in Performance Awards for Europe; Online Voting Opens at PioneersInPerformance.com
Charing Cross International Symposium
GORE® EXCLUDER® Iliac Branch Endoprosthesis Approved in Japan
Gore designed All-in-One System to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms
New Technology Add-On Payment Awarded for GORE® EXCLUDER® Iliac Branch Endoprosthesis
Recognition of new technology status will provide additional hospital reimbursement for IBE when used in FDA approved indications
Gore Launches Clinical Quality Improvement (CQI) Project of New Hernia Repair Device
New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial
Gore Prevails in Heart Device Patent Infringement Suit
W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.
First Successful Implant of GORE® SYNECOR Biomaterial in a Ventral Hernia Patient
Unique biomaterial for hernia repair implanted for the first time in Gore’s Clinical Quality Improvement project
Global Vascular Thought Leaders Document Shift toward Individualizing Patient Care in Surgical Bypass
Presentations and Discussions from the Surgical Bypass Summit Available at www.surgicalbypass.com